Ventricular tachycardia complicating alcohol septal ablation [7]

New England Journal of Medicine

Volumn 351, Issue 18, 2004, Pages 1914-1915

  Boltwood Jr , Chester M ^a   Chien, Walter ^a   Ports, Thomas ^b  

^a Valley Heart Assoc Medical Group   (United States)

^b UCSF Medical Center at Parnassus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; LIDOCAINE;

ADULT; CASE REPORT; CATHETER ABLATION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LETTER; MALE; PERCUTANEOUS TRANSLUMINAL SEPTAL MYOCARDIAL ABLATION; PRIORITY JOURNAL; ELECTROCARDIOGRAPHY; MIDDLE AGED; POSTOPERATIVE COMPLICATION;

CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ELECTROCARDIOGRAPHY; ETHANOL; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TACHYCARDIA, VENTRICULAR;

EID: 6944253543     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200410283511824     Document Type: Letter

References (5)

1. Seggewiss H. Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy. Curr Cardiol Rep 2001;3:160-6.
2. Kimmelstiel CD, Maron BJ. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 2004;109:452-6.
3. Crawford FA III, Killip D, Franklin J, Spencer WH III, Gold MR, Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation. Circulation 2003;108: Suppl IV:IV-386-IV-387.
4. Singh M, Edwards WD, Holmes DR Jr, Tajil AJ, Nishimura RA. Anatomy of the first septal perforating artery: a study with implications for ablation therapy for hypertrophic cardiomyopathy. Mayo Clin Proc 2001;76:799-802.
5. van Dockum WG, ten Cate FJ, Ten Berg JM, et al. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 2004;43:27-34.